Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 127
शीर्षक | मुख्य जाँचकर्ता | शुरुवाती साल | निधीयन एजेंसी | ध्यानाकर्षण क्षेत्र |
---|---|---|---|---|
Development of affordable synthetic route of Re-purposed small molecule drugs for the treatment of SARS-CoV-2 | Dr Parthasarathi Das, Associate Professor, Dr Somnath Yadav, Assistant Professor, Dr Soumitra Maity, Assistant Professor, Indian Institute of Technology (IIT), Dhanbad | 2020 | Drug repurposing for COVID-19 | |
Developing a novel effective therapeutic agent targeting pancreatic Cancer | Dr Ramesh Ummanni, Scientist, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | New molecule development against pancreatic cancer |
Adapt Ubiqare?s Specialty Care Platform to take care of COVID-19 patients during home quarantine and isolation ward stage | Sundararajan Srinivasan, Co-founder & CMD, ?Ubiqare Health Pvt Ltd, Bengaluru | 2020 | Specialty Care Platform for covid patients | |
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells | Dr Mirza S Baig, Associate Professor, Indian Institute of Technology (IIT) Indore | 2020 | Drug repurposing for COVID-19 | |
Development of vapour phase catalytic ammoxidation processes for the synthesis of aromatic nitriles | Dr N. Lingiah, Scientist, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Agrochemicals & Pharmaceuticals |
Virtual Screening and in vitro validation of SARS CoV-II Main Protease inhibitors | Dr Sharad Gupta, Associate Professor, Dr Mithun Radhakrishna, Assistant Professor, Indian Institute of Technology (IIT) Gandhinagar | 2020 | Drug repurposing for COVID-19 | |
Neutralizing Peptide Antibody Designed for Human Complement Fragment 5a (hC5a) | Dr Soumendra Rana, Assistant Professor, Indian Institute of Technology (IIT) Bhubaneswar | 2020 | Drug repurposing for COVID-19 | |
In silico screening for repurposing known drugs for SARS-CoV-2 using AI and molecular simulations | Prof. Jayant Kumar Singh, Professor, Indian Institute of Technology (IIT), Kanpur | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
Standardized Extracts and Biomarkers of Andrographis peniculata(Kalmegh) | Dr Shreyans Kumar Jain, Assistant Professor, Indian Institute of Technology (IIT), Varanasi | 2020 | Immune Modulator Against CONVID-19 | |
Development of new Smac Mimetic against chemotherapy resistant colon cancer | Dr Dipak Datta, Scientist, CSIR-Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | New molecule development against chemo-resistant colon cancer |